Home
 /
Papers
 /
Neuroscience
 /
The Extreme Diversity Of Retinal Amacrine Cells Has Deep Evolutionary Roots
Preprint
Open access
V1
Top 1% · Validated by QED

The Extreme Diversity Of Retinal Amacrine Cells Has Deep Evolutionary Roots

Dario Tommasini, Aboozar Monavarfeshani, Vishruth Dinesh +7 more
March 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.03.07.710289
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Neuroscience this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By identifying 42 orthologous amacrine cell types across 24 vertebrates, this study overturns the assumption that retinal inhibitory diversity is idiosyncratic, revealing a deep evolutionary logic that anchors cross-species neuroscience and disease modeling.

QED claims analysis

Summary

Integration of single-cell transcriptomic atlases across 24 vertebrate species reveals that amacrine cell diversity comprises 42 molecularly conserved orthologous types that originated over 500 million years ago in basal vertebrates, with GABAergic amacrine cells and retinal ganglion cells sharing common evolutionary ancestry from an AC-RGC hybrid precursor while glycinergic amacrine cells diverged earlier, and amacrine cell diversity scales linearly with retinal ganglion cell diversity across species indicating coordinated circuit evolution.

See full analysis
Main Claim 1 –

Amniote integration identifies 42 conserved amacrine cell orthotypes

Supporting evidence

  • All oACs classify as glycinergic or GABAergic by markers
  • Cross-species immunostaining validates novel orthotype molecular markers
  • Conserved transcription factor code structures amacrine cell heterogeneity
Main Claim 2 –

Most oACs conserved across mammals; conservation between BCs and RGCs

Main Claim 3 –

Amacrine cell diversity predates vertebrates, conserved to lamprey

Main Claim 4 –

Amacrine and ganglion cell diversity co-evolve across species

Abstract

Amacrine cells (ACs) comprise a heterogeneous class of inhibitory neurons in the vertebrate retina, exhibiting morphological and functional complexity rivaling that of cortical interneurons. Here, we integrate single-cell and single-nucleus transcriptomic atlases from 24 vertebrate species to reconstruct the evolutionary origins of this extreme diversity. We identify 42 orthologous AC types (oACs), most of which exhibit a one-to-one correspondence across amniotes and, in many cases, across vertebrates. While core molecular identities are conserved, AC types vary in abundance and gene expression across species, likely reflecting adaptations to distinct visual ecologies. AC diversity scales with that of retinal ganglion cells (RGCs), indicative of co-evolution. Finally, we suggest that ACs arose from an AC-RGC hybrid precursor, with glycinergic ACs diverging early in vertebrate evolution, followed by a bifurcation between RGCs and GABAergic ACs. Together, these findings establish a unified evolutionary framework for understanding the diversity, development, and function of a class of inhibitory neurons across vertebrates.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?